Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

Items 1-10 of 101

Page
per page
  1. ISCK03
    C3152 ISCK03
    Summary: inhibitor of SCF-mediated c-kit activation
      ≤2 mg/mL
  2. OSI-930
    A2838 OSI-930
    Summary: Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck
      ≥22.15 mg/mL
  3. Imatinib Mesylate (STI571)
    A1805 Imatinib Mesylate (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Abl/c-kit/PDGFR inhibitor
      ≥29.5 mg/mL
  4. HA-100 (hydrochloride)
    C4953 HA-100 (hydrochloride)
    Summary: inhibitor of protein kinases (PKs)
      insoluble in EtOH; ≥131.8 mg/mL
  5. SU5416
    A3847 SU5416
    Target: VEGFR
    Summary: VEGF receptor inhibitor and AHR agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  6. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL
  7. Amuvatinib (MP-470, HPK 56)
    A4237 Amuvatinib (MP-470, HPK 56)
    Summary: Tyrosine kinase inhibitor
      ≥22.4 mg/mL
  8. Danusertib (PHA-739358)
    A4116 Danusertib (PHA-739358)
     2 Citation
    Target: Aurora Kinases
    Summary: Pan-aurora kinase inhibitor
      ≥23.75 mg/mL
  9. Masitinib (AB1010)
    A2942 Masitinib (AB1010)
    Target: PDGFR|c-Kit|Lyn
    Summary: Tyrosine kinase inhibitor, potent and selective
      ≥24.95 mg/mL
  10. Regorafenib monohydrate
    A3751 Regorafenib monohydrate
    Summary: Tyrosine kinase inhibitor
      ≥25.05 mg/mL

Items 1-10 of 101

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 7item
  2. Axl 2item
  3. ALK 5item
  4. Broad Spectrum Protein Kinase Inhibitor 2item
  5. c-FMS 1 item
  6. c-Kit 7item
  7. c-MET 18item
  8. c-RET 7item
  9. EGFR 13item
  10. FAK 2item
  11. FGFR 5item
  12. FLT3 9item
  13. HER2 2item
  14. IGF1R 1 item
  15. Insulin Receptor 1 item
  16. Lck 1 item
  17. LRRK2 2item
  18. PDGFR 12item
  19. Pyk2 1 item
  20. ROR 2item
  21. Spleen Tyrosine Kinase (Syk) 3item
  22. Src 7item
  23. Tie-2 2item
  24. Trk 4item
  25. VEGFR 19item
Specificity
  1. Selective 41item
Reversibility
  1. Reversible 2item
  2. Irreversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 4item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. FLT3 4item
  6. Eph Receptors 1 item
  7. VEGFR 18item
  8. PDGFR 13item
  9. c-Kit 10item
  10. RET 1 item
  11. Bcr-Abl 4item
  12. FGFR 4item
  13. MET 5item
  14. Src 4item
  15. Trk Receptors 3item
  16. EGFR 7item
  17. FAK 1 item
  18. Syk 1 item
  19. ErbB 2item
  20. c-MET 7item
  21. PKC 1 item
  22. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  23. Lyn 1 item
  24. LRRK2 2item
  25. ALK 1 item
  26. Tie-2 2item
  27. Ron 1 item
  28. c-Fyn 1 item
  29. c-RET 1 item
  30. c-Fms tyrosine kinase 1 item
  31. insulin 1 item
  32. DCLK2 1 item
Reported Experiments
  1. Animal Experiments 52item
  2. Cell Experiments 39item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 9item
  7. Cancer 42item
  8. Cholangiocarcinoma 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 1 item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 8item
  13. Glioblastoma 5item
  14. Glioma 1 item
  15. Hepatocellular Carcinoma 1 item
  16. Leukemia 1 item
  17. Liver Cancer 2item
  18. Lung Cancer 3item
  19. Lung Carcinoma 2item
  20. Lymphoma 1 item
  21. Melanoma 1 item
  22. Multiple Myeloma 1 item
  23. Non-small Cell Lung Cancer 2item
  24. Ovarian Cancer 2item
  25. Pancreatic Cancer 8item
  26. Prostate Cancer 6item
  27. Renal Cell Carcinoma 3item
  28. Thyroid Cancer 2item